M
Mercedes Pons
Researcher at Rafael Advanced Defense Systems
Publications - 5
Citations - 685
Mercedes Pons is an academic researcher from Rafael Advanced Defense Systems. The author has contributed to research in topics: Hemodialysis & Transplantation. The author has an hindex of 5, co-authored 5 publications receiving 603 citations.
Papers
More filters
Journal ArticleDOI
High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients
Francisco Maduell,Francesc Moreso,Mercedes Pons,Rosa Ramos,Josep Mora-Macià,Jordi Carreras,Jordi Vallespir Soler,Ferran Torres,Josep M. Campistol,Alberto Martínez-Castelao +9 more
TL;DR: High-efficiency postdilution OL-HDF reduces all-cause mortality compared with conventional hemodialysis in patients with ESRD and the estimated number needed to treat suggested that switching eight patients from he modialysis to OL- HDF may prevent one annual death.
Journal ArticleDOI
Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections.
Alex Soriano,Joaquín Gómez,L. Gómez,José Ramón Azanza,Rubén Pérez,F. Romero,Mercedes Pons,F. Bella,María Velasco,Josep Mensa +9 more
TL;DR: The results suggest oral linezolid is an effective and well-tolerated alternative for treating OII and should be considered as a permanent treatment for orthopedic implant infections.
Journal ArticleDOI
Design and patient characteristics of ESHOL study, a Catalonian prospective randomized study.
Francisco Maduell,Francesc Moreso,Mercedes Pons,Rosa Ramos,Josep Mora-Macià,Andreu Foraster,Jordi Vallespir Soler,Josep M Galceran,Alberto Martínez-Castelao +8 more
TL;DR: The present study will contribute to evaluating the benefit for patient survival of OL-HDF over standard HD by comparing 3-year survival in prevalent end-stage renal disease patients randomized to OL- HDF or to continue on standard HD.
Journal ArticleDOI
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Néstor Fontseré,Celia Cardozo,Javier Donate,Alex Soriano,Mercedes Muros,Mercedes Pons,Josep Mensa,Josep M. Campistol,Juan F. Navarro-González,Francisco Maduell +9 more
TL;DR: The use of TCHLS to maintain the catheter lumen sterility significantly reduces the incidence of CRBSI and improves the inflammatory profile in hemodialysis patients with tunneled catheters.
Journal ArticleDOI
ESHOL study reanalysis: All-cause mortality considered by competing risks and time-dependent covariates for renal transplantation.
Francisco Maduell,Francesc Moreso,Josep Mora-Macià,Mercedes Pons,Rosa Ramos,Jordi Carreras,Jordi Vallespir Soler,Ferran Torres +7 more
TL;DR: The original results of the ESHOL study, which censored patients discontinuing the study for any reason, were confirmed in the present ITT population without censures and when all-cause mortality was considered by time-dependent and competing risks for transplantation.